-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Ambrx Biopharma, PaxMedica And 3 More Short Squeeze Stocks That Could Soar This Week
Ambrx Biopharma, PaxMedica And 3 More Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued to attract attention, with new traders looking for the next huge move.
High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.
Here's a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard.
Ambrx Biopharma: Clinical stage biopharmaceutical company Ambrx Biopharma (NYSE:AMAM) tops the list for the week, moving up three places. Data shows 39% of the float short and a cost to borrow of 98.7%, both among the highest on the leaderboard. The stock was the seventh most searched-for ticker on Benzinga Pro in the month of December, and has attracted investor attention after reporting preliminary safety and efficacy data from a Phase 2 study.
PaxMedica: Clinical stage biopharmaceutical company PaxMedica Inc (NASDAQ:PXMD) ranks second on the list, moving down one position from the last report. Data shows 26.9% of the float short and a cost to borrow of 747.6%. Both figures are up from the last report, and the cost to borrow is one of the highest recorded in recent months. PaxMedica has made frequent appearances on the short squeeze leaderboard over the last three months.
Cosmos Health: Pharmaceuticals company Cosmos Holdings Inc (NASDAQ:COSM) remains third on the leaderboard for the second straight week. The company has seen shares volatile since announcing a 1-for-25 reverse stock split. Fintel data shows 61.3% of the float short and a cost to borrow of 103.9%. The stock was the 12th most searched ticker on Benzinga in the month of December.
Aerovate Therapeutics: Biopharmaceutical company Aerovate Therapeutics (NASDAQ:AVTE) ranks fourth on the leaderboard, moving up one position from last week. Data shows 36.5% of the float short and a cost to borrow of 7.7%.
Huadi International: Chinese company Huadi International Group (NASDAQ:HUDI) ranks fifth on the leaderboard, seeing the biggest jump among the top five candidates with a 61-position move from last week. Data shows 12.2% of the float short and a cost to borrow of 86.5%. The stock was one of the most searched tickers on Benzinga Pro in November after announcing a business transition to clean energy initiatives.
The short squeeze stocks to watch list is published weekly. Benzinga also recently introduced its Moneymaker Index, which provides five stocks seeing increased interest from investors.
Related Link: How Do GameStop Style Short Squeezes Work Out For Retail Investors In The Long Run
Potential short squeeze plays gained steam in 2021 and have continued to attract attention, with new traders looking for the next huge move.
潛在的短擠壓在 2021 年引起了激烈的動作,並繼續引起人們的注意,新交易者正在尋找下一個巨大的舉動。
High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.
高短期利率和高借貸成本是可能導致短期擠壓的共同特徵之一。
Here's a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard.
以下是本週根據 Fintel 短擠壓排行榜的前五名短擠壓候選人。
Ambrx Biopharma: Clinical stage biopharmaceutical company Ambrx Biopharma (NYSE:AMAM) tops the list for the week, moving up three places. Data shows 39% of the float short and a cost to borrow of 98.7%, both among the highest on the leaderboard. The stock was the seventh most searched-for ticker on Benzinga Pro in the month of December, and has attracted investor attention after reporting preliminary safety and efficacy data from a Phase 2 study.
安布爾克斯生物製藥: 臨床階段生物製藥公司 安布爾克斯生物製藥 紐約證券交易所代碼:AMAM)在本週的榜首,向上移動了三個地方。數據顯示,浮動空頭的 39% 和 98.7% 的借貸成本,兩者都是排行榜上最高的。12 月份,該股票在 Beninga Pro 上搜索量最高的股票代碼排名第七,並在報告第二階段研究的初步安全性和有效性數據後引起了投資者的關注。
PaxMedica: Clinical stage biopharmaceutical company PaxMedica Inc (NASDAQ:PXMD) ranks second on the list, moving down one position from the last report. Data shows 26.9% of the float short and a cost to borrow of 747.6%. Both figures are up from the last report, and the cost to borrow is one of the highest recorded in recent months. PaxMedica has made frequent appearances on the short squeeze leaderboard over the last three months.
帕克斯梅迪卡: 臨床階段生物製藥公司 帕克斯梅迪卡公司 (NASDAQ:PXMD)在列表中排名第二,從上一個報告向下移動一個位置。數據顯示,短倉持倉量的 26.9% 及 747.6% 的借貸成本。這兩個數字均與上一份報告有所增加,而借貸成本是近月份錄得的最高數字之一。在過去的三個月裡,PaxMedica 在短擠排行榜上經常露面。
Cosmos Health: Pharmaceuticals company Cosmos Holdings Inc (NASDAQ:COSM) remains third on the leaderboard for the second straight week. The company has seen shares volatile since announcing a 1-for-25 reverse stock split. Fintel data shows 61.3% of the float short and a cost to borrow of 103.9%. The stock was the 12th most searched ticker on Benzinga in the month of December.
宇宙健康: 制药公司 宇宙控股 (納斯達克:COSM)連續第二週在排行榜上排行榜上排名第三。自宣布 1 對 25 反向股票拆股以來,該公司已經看到股票波動。芬特爾數據顯示 61.3% 的浮動空頭和 103.9% 的借貸成本。該股在十二月份是 Beninga 上搜索量最多的第 12 名股票。
Aerovate Therapeutics: Biopharmaceutical company Aerovate Therapeutics (NASDAQ:AVTE) ranks fourth on the leaderboard, moving up one position from last week. Data shows 36.5% of the float short and a cost to borrow of 7.7%.
氣卵酸鹽治療: 生物制藥公司 氣卵酸治療 (納斯達克:AVTE)在排行榜上排名第四,比上週向上移動一個位置。數據顯示持倉量的 36.5% 及 7.7% 的借貸成本。
Huadi International: Chinese company Huadi International Group (NASDAQ:HUDI) ranks fifth on the leaderboard, seeing the biggest jump among the top five candidates with a 61-position move from last week. Data shows 12.2% of the float short and a cost to borrow of 86.5%. The stock was one of the most searched tickers on Benzinga Pro in November after announcing a business transition to clean energy initiatives.
華迪國際: 中國公司 華迪國際集團 (NASDAQ:HUDI)在排行榜上排名第五,看到前五名候選人中最大的跳躍,距上週 61 位移動。數據顯示浮動空頭的 12.2%,借入成本為 86.5%。在宣布向清潔能源計劃進行業務過渡之後,該股票是 Beninga Pro 上搜索量最多的股票之一。
The short squeeze stocks to watch list is published weekly. Benzinga also recently introduced its Moneymaker Index, which provides five stocks seeing increased interest from investors.
要觀察的短擠壓股票列表每週發布一次。Beninga 最近還推出了賺錢指數,該指數為五隻股票提供了增加投資者的興趣。
Related Link: How Do GameStop Style Short Squeezes Work Out For Retail Investors In The Long Run
相關連結:從長遠來看,GameStop 風格短擠壓如何為散戶投資者工作
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧